AURODEX- antipyrine and benzocaine solution
Preferred Pharmaceuticals, Inc
Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
----------
Each mL Contains
Antipyrine ...........................................................54.0mg (5.4%)
Benzocaine ..........................................................14.0mg (1.4%)
(also contains glycerine and oxyquinoline sulfate)
Aurodextm Antipyrine and Benzocaine Otic Solution combines the hygroscopic property of anhydrous glycerin with the analgesic action of antipyrine and benzocaine to relieve pressure, reduce inflammation and congestion, and alleviate pain and discomfort in acute otitis media. Aurodextm Antipyrine and Benzocaine Otic Solution does not blanch the tympanic membrane or mask the landmarks and, therefore, does not distort the otoscopic picture.
Acute Otitis Media of Various Etiologies
- Prompt relief of pain and reduction of inflammation in the congestive and serous stages
- Adjuvant therapy during systemic antibiotic administration for rsolution of the infection.
Because the close anatomical relationship of the eustachian tube to the nasal cavity, otitis media is a frequesnt problem, especially in children in whom the tube is shorter, wider and more horizontal than in adults.
REMOVAL OF CERUMEN
- Facilitates the removal of excessive or impacted cerumen
Aurodextm Antipyrine and Benzocaine Otic Solution is contraindicated in any person with hypersensitivty to any of the components or substances related to them. This product is contraindicated in the presence of spontaneous perforation of the tympanic membrane or discharge
FOR USE IN EARS ONLY, NOT FOR USE IN EYES. KEEP OUT OF REACH OF CHILDREN.
Discontinue prompptly if sensitization or irritation occurs.
INFORMATION FOR PATIENTS:
Avoid contaminating the dropper tip with material from the ear, fingers or other source.
CATEGORY C: Animal reproductive studies have not been conducted with Aurodextm Antipyrine and Benzocaine Otic Solution. It is also not known whether AurodextmAntipyrine and Benzocaine Otic Solution can cause harm when adminstered to a pregnant woman, or can affect reproduction capacity. AurodextmAntipyrine and Benzocaine Otic Solution should be given to a pregnant woman onli if clearly needed.
It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be excercized when Aurodextm Antipyrine and Benzocaine Otic Solution is administered to a nursing woman
Instill Aurodextm Antipyrine and Benzocaine Otic Solution permitting the solution to run along the wall of the canal until it is filled. Avoid touching the ear with dropper. Then moisten a cotton pledget with Antipyrine and Benzocaine Otic Solution and insert into the meatus. Repeat every one to two hours until pain and congestion are relieved.
REMOVAL OF CERUMEN: Before: instll Aurodextm Antipyrine and Benzocaine Otic Solution three time daily fro two to three days to help detach cerumen from wall of canal and facilitate removal.
After:Aurodextm Antipyrine and Benzocaine Otic Solution is useful for drying out the canal and reliving discomfort.
Before and after removal of cerumen, a cotton pldget moistened with Antipyrine and Benzocaine Otic Solution should be inserted into the meatus following installation.
Note: After use, do not rinse dropper tip. Replace cap and close tightly.
Protect solution from light and heat, and do not use if it is brown or contains a precipitate.
DISCARD THIS PRODUCT SIX MONTHS AFTER OPENING
Aurodextm Antipyrine and Benzocaine Otic Solution is supplied in a 15 mL plastic bottle with a dropper tip under cap and package insert attached
NDC (68788-0008-01)
Store at 20o- 25o C (68o-77oF). Excursions permitted to 15o- 30o C (59o-786oF).
Manufactured By:
Sonar Products
Carlstadt, NJ 07072
Distributed By:
Major Pharmaceuticals
Livonia, MI
Relabeled by:
Preferred Pharmaceuticals, Inc
Anaheim, CA 92807
AURODEX
a/b otic drops solution |
||||||||||||
|
||||||||||||
|
||||||||||||
|
||||||||||||
|
||||||||||||
|
Labeler - Preferred Pharmaceuticals, Inc (791119022) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
Preferred Pharmaceuticals, Inc | 791119022 | REPACK(68788-0008) |